Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: "companies have been awaiting the outcome of US'336"

I think signings will increase dramatically once the USPTO removes Fish & Richardson's finger from the cracked dyke that is holding back an ocean of companies that are delaying. Today's signings indicate how weak that dyke is.

Rimmel took less than 2 months to deny the '9457 attempt. With all the legwork already done the new examiner should make shorter work of it this time around.

All IMHO

GLTAL

Share
New Message
Please login to post a reply